Q2 Earnings Forecast for PTGX Issued By HC Wainwright
Protagonist Therapeutics, Inc. (NASDAQ:PTGX – Free Report) – Investment analysts at HC Wainwright issued their Q2 2026 earnings estimates for shares of Protagonist Therapeutics in a report released on Wednesday, May 7th. HC Wainwright analyst D. Tsao expects that the company will earn ($0.72) per share for the quarter. HC Wainwright has a “Buy” rating […]
Protagonist Therapeutics, Inc. (NASDAQ:PTGX – Free Report) – Investment analysts at HC Wainwright issued their Q2 2026 earnings estimates for shares of Protagonist Therapeutics in a report released on Wednesday, May 7th. HC Wainwright analyst D. Tsao expects that the company will earn ($0.72) per share for the quarter. HC Wainwright has a “Buy” rating […]
